T1	SNP 6 15	rs1436904
T2	Entity 0 5	CHST9
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T3	Association 47 56	prognosis
E1	Association:T3 snp_int:T1 bc:T4
T4	Cancer 60 89	triple-negative breast cancer
A1	Cancer_Type T4 TNBC_and_or_Basal_like
T8	SNP 620 629	rs1436904
T9	Entity 614 619	CHST9
R4	SNP_coupled_gene Arg1:T8 Arg2:T9	
T10	SNP 639 647	rs527616
T11	Entity 634 638	AQP4
R5	SNP_coupled_gene Arg1:T10 Arg2:T11	
T12	Association 542 558	prognostic value
E2	Association:T12 snp_int:T8 snp_int2:T10 bc:T14
T13	Spec 529 537	evaluate
R6	Speculation_marker Arg1:E2 Arg2:T13	
T14	Cancer 684 700	early-stage TNBC
A5	Cancer_Type T14 TNBC_and_or_Basal_like
T15	SNP 816 825	rs1436904
T16	Entity 810 815	CHST9
R7	SNP_coupled_gene Arg1:T15 Arg2:T16	
T20	Effect_Type 868 877	decreased
T21	Entity 934 945	GG genotype
E4	Therapeutic_response:T22 Agent:T24
T23	Entity 906 909	DFS
T19	Entity 967 978	TT genotype
T24	SNP 816 825	rs1436904
R9	SNP_coupled_gene Arg1:T24 Arg2:T16	
A6	Effect_Type E4 Decrease
T17	Entity 878 904	disease-free survival time
R8	Equiv Arg1:T23 Arg2:T17	
T18	Level 912 930	8.5 months shorter
E3	Therapeutic_response:T22 Agent:T15
R10	Effect_type_marker Arg1:E3 Arg2:T20	
A7	Effect_Type E3 Decrease
A8	Level E3 High
R12	Level_marker Arg1:E3 Arg2:T18	
R13	Genotype Arg1:T15 Arg2:T21	
R14	Genotype Arg1:T24 Arg2:T19	
T25	Effect_Type 1062 1071	increased
T26	Association 1072 1076	risk
E5	Association:T26 bc:T27 snp_int:T29
R15	Effect_type_marker Arg1:E5 Arg2:T25	
A9	Effect_Type E5 Increase
T27	Cancer 1080 1086	cancer
T28	Entity 1102 1107	CHST9
T29	SNP 1108 1117	rs1436904
T30	Entity 1117 1125	G allele
R16	SNP_allele Arg1:T29 Arg2:T30	
T31	Entity 825 833	G allele
R17	SNP_allele Arg1:T15 Arg2:T31	
R18	SNP_allele Arg1:T24 Arg2:T31	
T32	Entity 1159 1176	tumor size > 2 cm
T33	Entity 1187 1208	lymph-node metastasis
T34	Entity 1216 1229	premenopausal
T35	Entity 1251 1268	vascular invasion
R20	SNP_coupled_gene Arg1:T29 Arg2:T28	
R22	Risk_Factor Arg1:T29 Arg2:T33	
T36	Neg 1179 1186	without
R23	Negation_marker Arg1:T33 Arg2:T36	
R24	Risk_Factor Arg1:T29 Arg2:T34	
R25	Risk_Factor Arg1:T29 Arg2:T35	
T38	SNP 1369 1378	rs1436904
T39	Entity 1355 1362	18q11.2
T40	Entity 1363 1368	CHST9
R27	SNP_coupled_gene Arg1:T38 Arg2:T40	
R28	SNP_location Arg1:T38 Arg2:T39	
T41	Association 1406 1417	contributes
E6	Association:T41 bc:T43 snp_int:T38
T42	Level 1392 1405	significantly
A10	Level E6 High
R29	Level_marker Arg1:E6 Arg2:T42	
T43	Cancer 1434 1450	early-stage TNBC
A11	Cancer_Type T43 TNBC_and_or_Basal_like
R30	Equiv Arg1:T27 Arg2:T43	
R19	Risk_Factor Arg1:T29 Arg2:T32	
T5	Cancer 696 700	TNBC
A2	Cancer_Type T5 TNBC_and_or_Basal_like
R2	Equiv Arg1:T5 Arg2:T4	
T6	Level 838 851	significantly
R3	Level_marker Arg1:E3 Arg2:T6	
R11	Effect_type_marker Arg1:E4 Arg2:T20	
T22	Therapeutic_response 878 904	disease-free survival time
